Immatics Announces First Bristol Myers Squibb Opt-in of TCR-

Bristol Myers Squibb exercised its first option and entered into a global license agreement with Immatics for the most advanced TCR-T product candidate from the companies’ ongoing collaboration... | May 1, 2023

Related Keywords

Germany , Anja Heuer , Bristol Myers Squibb , Harpreet Singh , Charlotte Spitz , Trophic Communications , Instagram , Linkedin , Twitter , Corporate Communications , Myers Squibb , Adoptive Cell Therapies , Looking Statements Immatics , Investor Relations , Immaticsnv Stock Exchange , News , Information , Press Release , Bristol , Myers , Squibb , Exercised , Its , First , Option , End , Ntered , Into , Lobal , License , Agreement , Ith , Immatics , Or , The , Most , Dvanced , Product , Candidate , Rom , Ngoing Imtx Nl0015285941 ,